Systemic mastocytosis: 2023 update on diagnosis and management in adults-Reference-Cited by-同舟云学术

Systemic mastocytosis: 2023 update on diagnosis and management in adults

Published:2023-06-06 Issue:3 Volume:28 Page:153-165
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Costa Alessandro¹,Scalzulli Emilia²,Carmosino Ida²,Capriata Marcello²,Ielo Claudia²,Masucci Chiara²,Passucci Mauro²,Martelli Maurizio²^ORCID,Breccia Massimo²^ORCID

Affiliation:

1. Hematology Unit, Businco Hospital, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy

2. Hematology, Department of Translational and Precision Medicine, Az. Policlinico Umberto I-Sapienza University, Rome, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728214.2023.2221028

Reference90 articles.

1. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts;Valent P;Blood,2017

2. Mast cell: a multi-functional master cell;Krystel-Whittemore M;Front Immunol,2016

3. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber DA;Blood,2016

4. International consensus classification of myeloid neoplasms and acute Leukemias: integrating morphologic, clinical, and genomic data;Arber DA;Blood,2022

5. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CT and Fluorine-18-Fluorodeoxyglucose (18F-FDG) PET/CT Imaging Findings of Aggressive Systemic Mastocytosis: A Case Report;Cureus;2024-07-18

2. Diagnosis of systemic mastocytosis with cryptic deletion of TET2 and DNMT3A resulting from unbalanced translocation;British Journal of Haematology;2024-05-04

3. Drug Design and Development for Rare Hematologic Diseases;Pharmaceuticals;2023-10-16